The RBQM Platform
Built for How Trials Actually Run
CluePoints RBQM is the operating model that connects risk, data, decisions, and action across the study lifecycle: the intelligence layer that turns risk signals into proportionate decisions, traceable actions, and inspection-ready oversight at every stage of every trial.
From Risk Signal to Inspection-Ready Evidence Across Your Entire Trial Portfolio
Most organizations can detect risk. The gap is what happens next. CluePoints RBQM, combining its Central Monitoring Platform (CMP) for cross-domain risk detection and Site Profile & Oversight Tool (SPOT) for site-level prioritization and action, is designed so that signals reliably lead to decisions, documented evidence, and inspection-ready outcomes.
CluePoints applies a depth of statistical analysis that threshold-based tools and AI-wrapper products cannot replicate. That analytical rigor is what turns risk signals into decisions your teams can act on, and regulators can inspect: the right data, surfaced at the right time, driving the right action.
Connected RBQM, From Signal to Action
How Teams Use CluePoints RBQM
Proactive Risk Detection Across Your Portfolio
CluePoints continuously analyzes clinical and operational data from every site and study, using advanced statistical methods to surface systemic risk patterns before they become protocol deviations or inspection findings. Central monitoring identifies the issues that matter, not just the ones that a pre-set threshold was configured to catch. But detection alone isn’t oversight. Every signal flows directly into a governed workflow where decisions are made, documented, and verified, so study teams act earlier and with confidence.
- KRI-based site ranking and tolerance monitoring
- QTL deviation tracking with automated alerts
- Cross-study risk trend visualization
Consistent Data Quality From First Patient to Database Lock
- Unsupervised statistical analysis across all data domains
- Duplicate and suspicious patient detection
- Patient profile review with atypicality scoring
Inspection-Ready Documentation at Every Stage
Inspectors increasingly focus not on whether risks were detected, but on how decisions were made and whether they were proportionate and traceable. CluePoints captures the complete evidence thread regulators expect: risk assessment and CtQ mapping, KRI/QTL configuration, signal investigation, action taken, and resolution confirmed. When RBQM is implemented as a connected operating model, inspection narratives emerge naturally from routine oversight.
- Versioned risk assessments with full stakeholder audit trail
- Signal-to-resolution documentation in a 21 CFR Part 11-compliant environment
- One-click TMF export and inspection package generation
Right Sites, Right Time, Right Level of Oversight
SPOT translates central monitoring risk signals into objective, multi-factor site risk scores, so that monitoring decisions are driven by data rather than intuition. Study managers and CRAs see exactly which sites need attention, why, and what to do next: targeted visits, adjusted SDV scope, or follow-up queries. Every decision is documented and defensible.
- Multi-factor site risk scoring updated continuously as data arrives
- Risk-adapted SDV and SDR targeting per site tier
- CRA performance and review completion tracking
Built for ICH E6(R3) Compliance
CluePoints operationalizes every element of ICH E6(R3), from QbD and CtQ factor mapping at study start, through KRI and QTL monitoring during execution, to documented signal investigation and resolution. Traceability, not complexity, drives inspection confidence. Your oversight narrative emerges naturally from routine practice, not retrospective documentation effort.
RBQM Solutions for Every Clinical Trial
Dive into CluePoints’ Resource Hub
Research, guides, webinars, and events. Everything you need to lead with RBQM.
Blog: The Bold Future of RBQM for CROs
Guide: Ultimate Guide to Modern RBQM
Webinar: RBQM Live On-Demand
